Related Experiment Video

Updated: Aug 8, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

Response to: "Rescuing the NIH before it is too late" from the Deputy Director for Extramural Research

Norka Ruiz Bravo

    The Journal of Clinical Investigation
    |May 11, 2006
    PubMed

    Abstract:

    For a number of reasons, the NIH and the biomedical research community are facing a period of fiscal constraint after pronounced growth. In these difficult times, it is important that we all speak from the facts and work together to do a better job of explaining the importance of the nation's investment in biomedical research.

    More Related Videos

    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
    16:26

    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

    Published on: August 20, 2007

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
    12:38

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

    Published on: July 19, 2007

    Related Experiment Videos

    Last Updated: Aug 8, 2026

    Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
    15:05

    Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

    Published on: February 5, 2015

    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
    16:26

    Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

    Published on: August 20, 2007

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
    12:38

    Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

    Published on: July 19, 2007

    Related Concept Videos

    Preclinical Development: Overview01:28

    Preclinical Development: Overview

    Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

    Articles linked to this work by shared authors, journal, and citation graph.

    The challenge for NIH ethics policies: preserving public trust and biomedical progress.

    Cleveland Clinic journal of medicine·2007

    Myotonic Muscle Activity Drives a Persistent Pain State Responsive to NaV1.8-directed Analgesics.

    The Journal of clinical investigation·2026

    Anti-PLA2R autoantibodies induce complement activation via IgG subclass-dependent epitope pairings in membranous nephropathy.

    The Journal of clinical investigation·2026

    Enhancing Gemcitabine Uptake by Promoting Dimerization of the ENT1 Transporter Improves Sarcoma Patient Response Rate.

    The Journal of clinical investigation·2026

    CD8⁺ Regulatory T Cells Shorten Neutrophil Lifespan to Reduce Hemorrhagic Transformation After Ischemic Stroke.

    The Journal of clinical investigation·2026

    Multiple sclerosis-associated CD226 variant disrupts vitamin D-induced type I Treg differentiation by impairing LFA-1 activation.

    The Journal of clinical investigation·2026

    Conserved neuronal-like and secretory programs define the spatial architecture of gastroenteropancreatic neuroendocrine tumors.

    The Journal of clinical investigation·2026

    Retraction: Neural correlates of risky monetary decision-making impacting others.

    Frontiers in human neuroscience·2026

    Mapping and modulating brain dynamics in aging and neurodegeneration with electroencephalography and integrated neurotechnologies in primates.

    Frontiers in neuroscience·2026

    Decoding sequence recognition code of nucleic acid-binding proteins of human-infecting DNA viruses.

    iMeta·2026

    Reduced Agitation in Psychiatric Inpatients Associated with Increased Exposure to Nicotine Replacement.

    Journal of dual diagnosis·2026

    Bored out of my mind: Integrated and flexible brain networks define trait boredom.

    Cognitive, affective & behavioral neuroscience·2026

    Mapping the dual functional organization of the substantia nigra.

    Molecular psychiatry·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us